Argus® II Retinal Prosthesis System Post-Market Surveillance Study

NCT01490827 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2020-05-21

No results posted yet for this study

Summary

This post-market surveillance study is conducted in the European Economic Area where Argus II has been CE certified for use in outer retinal degeneration patients.

Conditions

Sponsors & Collaborators

  • Second Sight Medical Products

    lead INDUSTRY

Principal Investigators

  • Anne-Marie Ripley · Second Sight Medical Products

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Germany
  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01490827 on ClinicalTrials.gov